Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction
Explore this paper's citation graph
Summary
With increasing age, heart failure with reduced ejection fraction patients less often received guideline-recommended medication prescriptions and also in a lower dosage, and a lower percentage of implantable cardioverter defibrillator and cardiac resynchronisation therapy device implantation in elderly patients was observed.
- Type
- article
- Published
- 2019-03-13
- Cited by
- 54
- References
- 29
- Access
- Open access
- OpenAlex
- https://openalex.org/W2920829402
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:76664810
Keywords
Medicine, Ejection fraction, Heart failure, Ivabradine, Internal medicine
References
- Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14 713 patients in the Swedish Heart Failure Registry
- Clinical profile, management, and mortality in very-elderly patients hospitalized with acute decompensated heart failure: An analysis from the ATTEND registry.
- Effects of cardiac resynchronization therapy on health-related quality of life in older adults with heart failure
- Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration.
- Treatment for chronic heart failure in the elderly: current practice and problems
- Influence of age and in‐patient care on prescription rate and long‐term outcome in chronic heart failure: a data‐based substudy of the EuroHeart Failure Survey
- Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).
- Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.
- Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF).
- BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
- Outcomes of Cardiac Resynchronization Therapy in the Elderly
- Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients or= 75 years of age treated with implantable cardioverter defibrillators.
- Which heart failure patients profit from natriuretic peptide guided therapy? A meta‐analysis from individual patient data of randomized trials
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- End-of-life preferences of elderly patients with chronic heart failure.
- Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
- Thirty‐year trends in heart failure hospitalization and mortality rates and the prognostic impact of co‐morbidity: a Danish nationwide cohort study
- Prevalence and prognostic impact of frailty and its components in non‐dependent elderly patients with heart failure
- Heart failure in elderly patients: differences in clinical characteristics and predictors of 1-year outcome in the Polish ESC-HF Long-Term Registry.
- Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
Cited by
- Age old problem: heart failure treatment in elderly
- Selección de lo mejor del año 2019 en cardiología geriátrica
- Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system.
- Treatment Differences in Chronic Heart Failure Patients With Reduced Ejection Fraction According to Blood Pressure
- Effect of physical and psychocognitive function and perceived health status on 12-month adverse cardiac events among implantable cardioverter-defibrillator recipients.
- Differences in guideline-recommended heart failure medication between Dutch heart failure clinics: an analysis of the CHECK-HF registry
- Care Gaps in Adherence to Heart Failure Guidelines: Clinical Inertia or Physiological Limitations?
- Remote Monitoring in Chronic Heart Failure Patients: Is Non-Invasive Remote Monitoring the Way to Go?
- CardioMEMS™: a tool for remote hemodynamic monitoring of chronic heart failure patients.
- Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure.
- Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction
- Diabetes and treatment of chronic heart failure in a large real‐world heart failure population
- Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction
- Temporal trends in characteristics, treatment, and outcomes of heart failure in octogenarians over two decades.
- Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly
- Tendencias temporales en las características, tratamiento y resultados de la insuficiencia cardiaca en octogenarios durante dos décadas
- Pharmakologische Therapie kardiologischer Erkrankungen im Alter
- Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
- Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
- Adherence and Discontinuation of Optimal Heart Failure Therapies According to Age: A Danish Nationwide Study
Related papers
- Clinical Efficacy of Ivabradine
- Advances in Using Ivabradine in Cardiovascular Disease
- Characterization of the Heart Rate-Lowering Action of Ivabradine, a Selective If Current Inhibitor
- Ivabradine, A Heart Rate Lowering Drug: A Clinical Investigation
- Role of ivabradine in pediatrics: A review article
- Ivabradine for treatment of tachyarrhythmias in children and young adults
- Why do I use ivabradine in my patients?
- Clinical Results of If Current Inhibition by Ivabradine
- Limited role and benefit of ivabradine in the treatment of angina and heart failure with reduced ejection fraction
- Heart rate reduction in heart failure: ivabradine or beta blockers?